Overview

N-acetylcysteine for Tobacco Use Disorder

Status:
Completed

Trial end date:
2019-10-10

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the effects of administering N-Acetylcysteine (NAC) to assist in initial cessation and/or relapse prevention in adult cigarette smokers.

Phase:

Phase 2

Details

Lead Sponsor:

Medical University of South Carolina

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Acetylcysteine
N-monoacetylcystine